Thiol-based redox regulation has emerged as the prevalent mechanism for redox regulation of cellular processes. Its major component, the thioredoxin (Trx) system, is present in all organisms. Thioredoxin reductases (TRs) control the redox state of Trxs, which in turn regulate cellular processes by controlling the redox state of Trxs. TRs and Trxs have been implicated in cancer development, apoptosis, signal transduction and many other processes, but the pathways and mechanisms of thiol-based regulation are poorly understood. Mammals have three TRs: cytosolic TR1 (Txnrd1), mitochondrial TR3 (Txnrd2) and thioredoxin/glutathione reductase TGR (Txnrd3). All three contain a catalytic selenocysteine in the C-terminal region and, therefore, the mammalian Trx system is dependent on dietary selenium. In addition, each TR has several isoforms that differ by their N-terminal sequences. Among TR substrates, previous studies focused on Trx1 and few other thiol oxidoreductases (i.e., proteins that use catalytic redox Cys). However, there are numerous other Trx-like proteins and thiol oxidoreductases, and the overall composition of this system and identity of proteins regulated by thiol oxidoreductases is not known. This is important because thiol oxidoreductases provide a framework for redox regulation of cellular processes by targeting redox Cys residues in proteins. Previously, we defined the basic properties of TRs and their roles in various biological processes, organs and organisms. Additional data revealed successful application of mechanism-based approaches to identify substrates of TRs and thiol oxidoreductases. Computational approaches were also developed that allow identification of entire sets of thiol oxidoreductases in organisms. We now propose to use this foundation to characterize isoforms of TRs, their thiol oxidoreductase substrates and protein targets of thiol oxidoreductases to define the major pathway of thiol-based redox regulation in mammals. To address this challenge, we propose the following specific aims: (1) Characterize regulation of TR function and redox homeostasis by heterodimerization and position-specific Sec insertion. (2) Determine specific substrates of mammalian TR isoforms. (3) Define a mammalian set of thiol oxidoreductases and their protein targets. A combination of computational, proteomic, cell biology, and animal model approaches will be used to address these questions, and the data will be used to define the network of thiol-based redox regulation of protein function in mammals.

Public Health Relevance

A redox system composed of thioredoxin reductase and thioredoxin is the main regulator of the redox state of cysteines in proteins, whereby controlling cellular redox homeostasis and major metabolic processes. This system has been implicated in cell signaling, apoptosis, cancer development, and many other physiological and pathophysiological processes. Using computational, proteomic, cell biology, and animal model approaches, we propose to determine functions of thioredoxin reductase isoforms, their thiol oxidoreductase substrates and identities of downstream targets to define a skeleton of thiol-based redox regulation in mammals.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM065204-13
Application #
8583326
Study Section
Special Emphasis Panel (ZRG1-EMNR-H (02))
Program Officer
Barski, Oleg
Project Start
2002-05-01
Project End
2015-11-30
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
13
Fiscal Year
2014
Total Cost
$349,316
Indirect Cost
$142,314
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Golubev, Alexey; Hanson, Andrew D; Gladyshev, Vadim N (2017) A Tale of Two Concepts: Harmonizing the Free Radical and Antagonistic Pleiotropy Theories of Aging. Antioxid Redox Signal :
Renko, Kostja; Martitz, Janine; Hybsier, Sandra et al. (2017) Aminoglycoside-driven biosynthesis of selenium-deficient Selenoprotein P. Sci Rep 7:4391
Moskalev, Alexey; Anisimov, Vladimir; Aliper, Aleksander et al. (2017) A review of the biomedical innovations for healthy longevity. Aging (Albany NY) 9:7-25
Ke, Zhonghe; Mallik, Pramit; Johnson, Adam B et al. (2017) Translation fidelity coevolves with longevity. Aging Cell 16:988-993
Gerashchenko, Maxim V; Gladyshev, Vadim N (2017) Ribonuclease selection for ribosome profiling. Nucleic Acids Res 45:e6
Lobanov, Alexei V; Heaphy, Stephen M; Turanov, Anton A et al. (2017) Position-dependent termination and widespread obligatory frameshifting in Euplotes translation. Nat Struct Mol Biol 24:61-68
Golubev, Alexey; Hanson, Andrew D; Gladyshev, Vadim N (2017) Non-enzymatic molecular damage as a prototypic driver of aging. J Biol Chem 292:6029-6038
Lee, Sang-Goo; Kaya, Alaattin; Avanesov, Andrei S et al. (2017) Age-associated molecular changes are deleterious and may modulate life span through diet. Sci Adv 3:e1601833
Kaya, Alaattin; Mariotti, Marco; Gladyshev, Vadim N (2017) Cytochrome c peroxidase facilitates the beneficial use of H2O2 in prokaryotes. Proc Natl Acad Sci U S A 114:8678-8680
Manta, Bruno; Gladyshev, Vadim N (2017) Regulated methionine oxidation by monooxygenases. Free Radic Biol Med 109:141-155

Showing the most recent 10 out of 71 publications